In this study, we evaluate whether patient-derived ECFCs demonstrate their own reservoir of MPO that may contribute to mitochondrially-associated endothelial dysfunction and CAD in a unique CTCA-characterised cohort and biobank. The gene discussed is MPO; the disease is coronary artery disorder.